Enhanced therapeutic effects of anti-tumour agents against growth and metastasis of colon carcinoma 26 when given in combination with interferon and interleukin-2

Clinical & Experimental Metastasis

Volumn 12, Issue 6, 1994, Pages 368-374

  Iigo, Masaaki ^a   Tsuda, Hiroyuki ^a   Moriyama, Masami ^b  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b Basic Research Laboratories   (Japan)

Author keywords

colon carcinoma 26; etoposide; interferon; interleukin 2; pulmonary metastasis

Indexed keywords

ANTINEOPLASTIC AGENT; BETA INTERFERON; CD8 ANTIGEN; CISPLATIN; CYTOKINE; ETOPOSIDE; INTERLEUKIN 2;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER IMMUNOTHERAPY; COLON CARCINOMA; CONTROLLED STUDY; HISTOLOGY; INTRAVENOUS DRUG ADMINISTRATION; LUNG METASTASIS; MALE; MOUSE; NONHUMAN; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE SUBPOPULATION;

ANIMAL; CARCINOMA; CISPLATIN; COLONIC NEOPLASMS; DRUG THERAPY, COMBINATION; ETOPOSIDE; INTERFERON-BETA; INTERLEUKIN-2; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS;

EID: 0028135502     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/BF01755880     Document Type: Article

References (13)

1. Synergistic inhibition of the growth of adenocarcinoma 755 by the combination of interleukin-2 and interferon-β
2. In vivo anti-tumor activity of combinations of interferon alpha and interleukin-2 in a murine model. Correlation of efficacy with the induction of cytotoxic cells resembling natural killer cells
3. In vivo antitumor activity of multiple injections of recombinant interleukin 2, alone and in combination with three different types of recombinant interferon, on various syngeneic murine tumors
4. Synergistic antitumor effects of combination immunotherapy with recombinant interleukin-2 and a recombinant hybrid α-interferon in the treatment of established murine hepatic metastases
5. Combination immunotherapy for cancer: synergistic antitumor interactions of interleukin-2, alfa interferon, and tumor-infiltrating lymphocytes
6. Combination therapy of colon carcinoma 26 in mice with recombinant human interleukin-2 and interferon-αA/D: occurrence of large granular cells in the tumor
7. Effects of interleukin-2 and interferon-αA/D treatment on lymphocytes from tumor-bearing mice
8. Changes in lymphocyte subsets following multiple administration of recombinant interleukin-2 plus recombinant interferon-beta or -gamma in tumor-bearing mice
9. Combination therapy with interleukin-2 and alphainterferon for the treatment of patients with advanced cancer
10. Sequential chemoimmunotherapy in the treatment of metastatic melanoma
11. Chemoimmunotherapy of metastatic malignant melanoma. The Salpétrière Hospital (SOMPS) experience
12. Interleukin-2 in combination with interferon-α and 5-fluorouracil for metastatic renal cell cancer
13. Flow cytometric analysis reveals the presence of asialo GM1 on the surface membrane of alloimmune cytotoxic T lymphocytes